EconPapers    
Economics at your fingertips  
 

Subsidizing access to prescription drugs and health outcomes: The case of diabetes

Pedro Américo () and Rudi Rocha

Journal of Health Economics, 2020, vol. 72, issue C

Abstract: This paper evaluates the health effects of a large-scale subsidizing program of prescription drugs introduced in Brazil, the Aqui Tem Farmácia Popular program (ATFP). We exploit features of the program to identify its effects on mortality and hospitalization rates by diabetes for individuals aged 40 years or more. We find weak evidence for a decline in mortality, but a robust reduction in hospitalization rates. According to our preferred specification, an additional ATFP pharmacy per 100,000 inhabitants is associated with a decrease in hospitalization rates by diabetes of 8.2, which corresponds to 3.6% of its baseline rate. Effects are larger for Type II diabetes in comparison to Type I, and among patients with relatively lower socioeconomic status. Overall, the results are consistent with insulin-dependent patients being relatively less responsive to subsidies because of higher immediate life-threatening risks; and with lower-SES individuals being more responsive because of liquidity constraints. These results support the view that the optimal design of health systems and cost-sharing mechanisms should take into account equity concerns, heterogeneous impacts by health condition, and their potential offsetting effects on the utilization of downstream health services.

Keywords: Subsidies; Prescription drugs; Diabetes; Hospital admissions; Mortality (search for similar items in EconPapers)
JEL-codes: H51 I10 I13 I18 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167629619308434
Full text for ScienceDirect subscribers only

Related works:
Working Paper: Subsidizing Access to Prescription Drugs and Health Outcomes: The Case of Diabetes (2020) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:jhecon:v:72:y:2020:i:c:s0167629619308434

DOI: 10.1016/j.jhealeco.2020.102347

Access Statistics for this article

Journal of Health Economics is currently edited by J. P. Newhouse, A. J. Culyer, R. Frank, K. Claxton and T. McGuire

More articles in Journal of Health Economics from Elsevier
Bibliographic data for series maintained by Catherine Liu ().

 
Page updated 2022-05-09
Handle: RePEc:eee:jhecon:v:72:y:2020:i:c:s0167629619308434